London - Imperial College London

Horizontal Tabs

Treatment Modalities 
Small Molecules
Biologics
Immunotherapy
Radiotherapy
Chemoradiotherapy
Surgery
Gene therapy

ECMC funding provides infrastructure support for early phase and translational research.  From the ECMC London Imperial portfolio, the following trials have been carried out.

 
Trial activity between 2012-2015:

Trial by disease type between 2012-2015:

 

Imperial has outstanding expertise in the discovery of biomarkers related to drug resistance and in the development of new approaches for cancer diagnosis and treatment through imaging. genomic, epigenomic and metabolomic technologies